Trademark: 90106436
Word
QDOLO
Status Date
Tuesday, December 28, 2021
Registration Number
6603833
Registration Date
Tuesday, December 28, 2021
Filing Date
Tuesday, August 11, 2020
Published for Opposition
Tuesday, January 12, 2021
5 Pharmaceutical preparations for the treatment of and management of pain, premature ejaculation, depression, anxiety, restless leg syndrome, and opioid use disorder
In the statement, line 1, "Pharmaceuticals" should be deleted, and "Bioscience" should be inserted.
Aug 14, 2020
New Application Entered
Sep 11, 2020
New Application Office Supplied Data Entered
Dec 4, 2020
Approved For Pub - Principal Register
Dec 4, 2020
Assigned To Examiner
Jan 12, 2021
Published For Opposition
Dec 23, 2020
Notification Of Notice Of Publication E-Mailed
Mar 9, 2021
Noa E-Mailed - Sou Required From Applicant
Jan 12, 2021
Official Gazette Publication Confirmation E-Mailed
Oct 12, 2021
Abandonment Notice E-Mailed - No Use Statement Filed
Sep 9, 2021
Sou Extension 1 Filed
Oct 11, 2021
Abandonment - No Use Statement Filed
Oct 19, 2021
Teas Statement Of Use Received
Oct 19, 2021
Petition To Revive-Granted
Oct 19, 2021
Use Amendment Filed
Nov 15, 2021
Statement Of Use Processing Complete
Oct 19, 2021
Teas Petition To Revive Received
Oct 19, 2021
Sou Extension Received With Teas Petition
Oct 20, 2021
Notice Of Revival - E-Mailed
Nov 9, 2021
Case Assigned To Intent To Use Paralegal
Nov 15, 2021
Sou Extension 1 Granted
Nov 22, 2021
Allowed Principal Register - Sou Accepted
Nov 16, 2021
Notice Of Approval Of Extension Request E-Mailed
Nov 23, 2021
Notice Of Acceptance Of Statement Of Use E-Mailed
Dec 28, 2021
Registered-Principal Register
Sep 12, 2024
Case Assigned To Post Registration Paralegal
Sep 17, 2024
Correction Under Section 7 - Processed
Feb 29, 2024
Teas Section 7 Request Received
Trademark Alertz updated from USPTO on 2030-01-24
